Skip Nav Destination

Issue Archive

Select Year

Issue

Volume 22, Issue 1

January-February 2025

In this Issue

Ask the Hematologist
Clinical Trials Corner
Feature
Headlines from Washington
In Memoriam
Mini Review
President’s Column
The Year’s Best

Ask the Hematologist

Idiopathic Multicentric Castleman Disease: Still a Diagnostic Conundrum?

Frits Van Rhee, MD, PhD

View Articletitled, Idiopathic Multicentric Castleman Disease: Still a Diagnostic Conundrum?

Diagnosis and Management of Non-HFE Hemochromatosis

Michael Scott, MD

View Articletitled, Diagnosis and Management of Non-HFE Hemochromatosis

Clinical Trials Corner

BLySfully BAFFled: The Expanding Immune Thrombocytopenia Armamentarium

Richard C. Godby, MD,Surbhi Shah, MD

View Articletitled, BLySfully BAFFled: The Expanding Immune Thrombocytopenia Armamentarium

Feature

The Universe Continues to Expand: Reflections From the 2024 ASH Annual Meeting

Joselle M. Cook, MBBS,Juliana Perez Botero, MD

View Articletitled, The Universe Continues to Expand: Reflections From the 2024 ASH Annual Meeting

Technology Spotlight
Surface Target Discovery for Blood Cancer Immunotherapies

Bonell Patiño-Escobar, MD,Lucy Perez-Lugo, MD,Arun P. Wiita, MD, PhD

View Articletitled, Technology Spotlight Surface Target Discovery for Blood Cancer Immunotherapies

Headlines from Washington

Headlines From Washington

View Articletitled, Headlines From Washington

In Memoriam

Honoring a Champion of ASH and Hematology

Steven L. Allen, MD,Chancellor Donald, MD

View Articletitled, Honoring a Champion of ASH and Hematology

Mini Review

Minimal Residual Disease as a Primary Endpoint in Multiple Myeloma: Implications for Clinical Trials and Everyday Clinical Practice

Anupama D. Kumar, MD,Alfred Chung, MD,Ajai Chari, MD

View Articletitled, Minimal Residual Disease as a Primary Endpoint in Multiple Myeloma: Implications for Clinical Trials and Everyday Clinical Practice

President’s Column

Let’s Grow Together in 2025

Belinda R. Avalos, MD

View Articletitled, Let’s Grow Together in 2025

The Year’s Best

The Road Less Traveled: T Cell-Engaging Immunotherapies for Myeloid Malignancies

Zoë C. Wong, BS,Bethan Psaila, MD, PhD

View Articletitled, The Road Less Traveled: T Cell-Engaging Immunotherapies for Myeloid Malignancies

Sickle Cell Disease in 2024: One Step Forward and Two Steps Back

Samuel R. Wilson, MD, MSCR,Jane A. Little, MD

View Articletitled, Sickle Cell Disease in 2024: One Step Forward and Two Steps Back

‘Blin’-ing Is Winning for Children With B-Cell Acute Lymphoblastic Leukemia

Lauren Pommert, MD, MS,Sarah K. Tasian, MD

View Articletitled, ‘Blin’-ing Is Winning for Children With B-Cell Acute Lymphoblastic Leukemia

New Targets in Refractory Chronic Graft-Versus-Host Disease

Kate A. Markey, MBBS, PhD

View Articletitled, New Targets in Refractory Chronic Graft-Versus-Host Disease

Antibody-Drug Conjugates Show Promise in Development of Targeted Therapy for T-Cell Lymphomas

Elizabeth L. Courville, MD

View Articletitled, Antibody-Drug Conjugates Show Promise in Development of Targeted Therapy for T-Cell Lymphomas

Game of Thrones: The New King in Advanced-Stage Hodgkin Lymphoma

Tycel Phillips, MD

View Articletitled, Game of Thrones: The New King in Advanced-Stage Hodgkin Lymphoma

The Rise of the HLA-Mismatched Unrelated Donor Transplant in the U.S.

Lori Muffly, MD, MS

View Articletitled, The Rise of the HLA-Mismatched Unrelated Donor Transplant in the U.S.

Blurring the Lines: Beyond Using Transplant Eligibility to Guide Induction Therapy in Myeloma

Darren Pan, MD,Anupama Kumar, MD,Alfred Chung, MD,Ajai Chari, MD

View Articletitled, Blurring the Lines: Beyond Using Transplant Eligibility to Guide Induction Therapy in Myeloma

The End of Transplant for Mantle Cell Lymphoma

Brian T. Hill, MD, PhD

View Articletitled, The End of Transplant for Mantle Cell Lymphoma

Cover Image

Cover Image

All Issues

Advertisement intended for health care professionals

Email alerts

Latest Issue Alert

Continuous Publishing Alert

New Journal Content Alert

Latest
Most Read

Antibody-Drug Conjugates Show Promise in Development of Targeted Therapy for T-Cell Lymphomas

Game of Thrones: The New King in Advanced-Stage Hodgkin Lymphoma

The Rise of the HLA-Mismatched Unrelated Donor Transplant in the U.S.

Blurring the Lines: Beyond Using Transplant Eligibility to Guide Induction Therapy in Myeloma

The End of Transplant for Mantle Cell Lymphoma

Advertisement intended for health care professionals

Table of Contents

Ask the Hematologist

Idiopathic Multicentric Castleman Disease: Still a Diagnostic Conundrum?

Diagnosis and Management of Non-HFE Hemochromatosis

Clinical Trials Corner

BLySfully BAFFled: The Expanding Immune Thrombocytopenia Armamentarium

Feature

The Universe Continues to Expand: Reflections From the 2024 ASH Annual Meeting

Technology Spotlight
Surface Target Discovery for Blood Cancer Immunotherapies

Headlines from Washington

Headlines From Washington

In Memoriam

Honoring a Champion of ASH and Hematology

Mini Review

Minimal Residual Disease as a Primary Endpoint in Multiple Myeloma: Implications for Clinical Trials and Everyday Clinical Practice

President’s Column

Let’s Grow Together in 2025

The Year’s Best

The Road Less Traveled: T Cell-Engaging Immunotherapies for Myeloid Malignancies

Sickle Cell Disease in 2024: One Step Forward and Two Steps Back

‘Blin’-ing Is Winning for Children With B-Cell Acute Lymphoblastic Leukemia

New Targets in Refractory Chronic Graft-Versus-Host Disease

Antibody-Drug Conjugates Show Promise in Development of Targeted Therapy for T-Cell Lymphomas

Game of Thrones: The New King in Advanced-Stage Hodgkin Lymphoma

The Rise of the HLA-Mismatched Unrelated Donor Transplant in the U.S.

Blurring the Lines: Beyond Using Transplant Eligibility to Guide Induction Therapy in Myeloma

The End of Transplant for Mantle Cell Lymphoma

Email alerts

ASH Publications

American Society of Hematology

Issue Archive

Table of Contents

Ask the Hematologist

Clinical Trials Corner

Feature

Headlines from Washington

In Memoriam

Mini Review

President’s Column

The Year’s Best

Cover Image

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only